Autologous immune enhancement therapy against an advanced epithelioid sarcoma: A case report. - Wikidata - thesis-toulmin - TriplyDB

Autologous immune enhancement therapy against an advanced epithelioid sarcoma: A case report.

Autologous immune enhancement therapy against an advanced epithelioid sarcoma: A case report.

http://www.wikidata.org/entity/Q34350552

about

Potential for immunotherapy in soft tissue sarcoma Current Immunotherapies for Sarcoma: Clinical Trials and Rationale Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma.Immunotherapies in sarcoma: Updates and future perspectives

P2860

Q27008830-52886360-2EE2-4631-A29F-F7FC222FBD6E Q28067036-970341BD-D2F2-47B8-9F9E-595C432F98B1 Q35832436-18821CB9-2340-458E-8277-5AE1B7F46B0F Q37743055-00F1A1C1-C917-401B-B6DB-036FA2A3B46C

P2860

Autologous immune enhancement therapy against an advanced epithelioid sarcoma: A case report.

http://www.wikidata.org/entity/Q34350552

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Autologous immune enhancement ...... elioid sarcoma: A case report.

@ast

Autologous immune enhancement ...... elioid sarcoma: A case report.

@en

Autologous immune enhancement ...... elioid sarcoma: A case report.

@nl

type

label

Autologous immune enhancement ...... elioid sarcoma: A case report.

@ast

Autologous immune enhancement ...... elioid sarcoma: A case report.

@en

Autologous immune enhancement ...... elioid sarcoma: A case report.

@nl

prefLabel

Autologous immune enhancement ...... elioid sarcoma: A case report.

@ast

Autologous immune enhancement ...... elioid sarcoma: A case report.

@en

Autologous immune enhancement ...... elioid sarcoma: A case report.

@nl

P1433

Q34350552-46C8055F-FDAD-4BFB-8697-CCC6F9A5ACEF

P1476

Q34350552-4177CEC3-7069-44C7-AF5E-52B4FE9E12DF

P2093

Q34350552-134AAB87-E5D5-48DB-8F88-08AD74D16750

Q34350552-159DD013-F957-451F-922E-1AC71E4E4CC2

Q34350552-1AA64F75-D1AF-49E3-BBE3-3039AF5D156B

Q34350552-2A87AFBC-F4C3-4766-BFCF-26F749624208

Q34350552-6444000A-DA0E-4972-B3B5-7FB2930AD4EA

Q34350552-7F7EE26C-1CC6-4214-99C8-8216F9926F75

Q34350552-9FD6B7C6-8766-4944-9049-285B6634BDCC

Q34350552-FF464237-2A03-43EE-80D6-397716BEA1A5

P2860

Q34350552-11769C9C-7030-4FDC-B2A9-FC941EEEA483

Q34350552-1187EFAD-9C7F-4A68-A916-72B0C81DC74B

Q34350552-14977B14-7B31-4F3F-9A8B-5915D28B86A5

Q34350552-221A7B83-6F5C-4079-825E-5C647546C866

Q34350552-2EBC2123-784F-47F2-ACF1-AB5EAEBAEAA5

Q34350552-36C99A1D-BD38-43CE-817B-B22E4889B220

Q34350552-395C801F-CF9D-430E-919C-F905A52A47C4

Q34350552-488FD030-C75A-4A98-9D61-CDBE8EE82A14

Q34350552-4A6390E1-0EFA-49E7-9CEB-275F786CB539

Q34350552-4B540690-0ABE-416B-A3B5-885FA7FE9F9C

P304

Q34350552-B3A420C3-267A-4CB0-A02A-67520A88C035

P31

Q34350552-A76EC716-C8BF-4AD5-AEF2-53A7C4620295

P356

Q34350552-B42891DF-82DE-4C7A-9A92-7E4A206549EC

P433

Q34350552-ECE741C1-4257-43F1-8A00-C44D31578129

P478

Q34350552-667A5AD4-70F6-4ABC-A26D-B785DDED5F0C

P50

Q34350552-D33A07C6-AAE3-4509-918A-1C941FA7F2D7

P577

Q34350552-08F44108-5B0C-4DE8-88B9-79B04A3D26C9

P5875

Q34350552-1EA7C763-3220-4942-A6D0-51867B2C7820

P698

Q34350552-228BD1EF-6E6F-4A49-9D9D-1FAEDE8433CE

P932

Q34350552-E4DA14A9-BB54-4E82-A8C4-D102260A001B

P356

P1433

Oncology Letters

P1476

Autologous immune enhancement ...... elioid sarcoma: A case report.

@en

P2093

Baskar Subramani

http://www.w3.org/2001/XMLSchema#string

Chithra Ramanathan Pullai

http://www.w3.org/2001/XMLSchema#string

Kananathan Ratnavelu

http://www.w3.org/2001/XMLSchema#string

Kohila Krishnan

http://www.w3.org/2001/XMLSchema#string

Manjunath Sadananda Rao

http://www.w3.org/2001/XMLSchema#string

Sheela Devi Sugadan

http://www.w3.org/2001/XMLSchema#string

Terunuma Hiroshi

http://www.w3.org/2001/XMLSchema#string

Xuewen Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the management of soft tissue sarcomas

Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report

Immunotherapeutic Intervention against Sarcomas.

Soft tissue sarcoma as a model disease to examine cancer immunotherapy.

Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.

Epithelioid sarcoma: the University of Washington experience.

Symptom burden, survival and palliative care in advanced soft tissue sarcoma.

Case-control study: soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols.

Soft-tissue sarcomas in adults.

Osteosarcoma: current status of immunotherapy and future trends (Review).

P304

1457-1460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2013.1247

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Abhi Veerakumarasivam

P577

2013-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237843955

http://www.w3.org/2001/XMLSchema#string

P698

23761810

http://www.w3.org/2001/XMLSchema#string

P932

3678875

http://www.w3.org/2001/XMLSchema#string